Treatment patterns and outcomes in the DLBCL cohort of a study (MONITOR‐GCSF) assessing biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropenia. (June 2017) - Gascon, P.; Krendyukov, A.; Höbel, N.; Aapro, M.